EHC2013


Go to content

Call For Abstracts

Call for Abstracts

The abstract submission is closed.

 

The Scientific Committee would like to thank everyone who has submitted abstracts.

 

Deadline

Deadline for abstract submission was 15 December 2012, 8pm local UAE time.

 

Guidelines for Abstract Submission

A special criterion for accepting abstracts will be their topic as well as structure, content
and degree of innovation.

 

Structure of the Abstract

The structure of the abstract should be as follows:

a.

Background and Purpose

b.

Methods

c.

Results

d.

Conclusions

   

-

Please note that a maximum of 300 words is permitted.

-

The titles and the names of the authors are excluded from this number and have
to be entered separately.

-

Tables should not be included in the abstract body.

-

Methods section should include type of statistical analysis done if applicable to the
study.

-

Statements such as "Results will be discussed"; are not acceptable and may lead
to a rejection of the abstract.

 

Abstract Topics

1.

Red Blood Cells and Iron; Physiology and Disease (Anemia)

2.

Transfusion Medicine

3.

Acute Lymphoblastic Leukemia

4.

Acute Myeloid Leukemia

5.

Chronic Lymphocytic Leukemia and Related Disorders

6.

Chronic Myeloid Leukemia

7.

Hodgkin's Lymphoma

8.

MDS and Bone Marrow Failure Syndromes including PNH

9.

Myeloma and other Monoclonal Gammopathies

10.

Myeloproliferative Disorders

11.

Non-Hodgkin's Lymphoma

12.

Stem Cell Transplantation

13.

Cytogenics and Molecular Diagnostics

14.

Drug Resistance and Pharmacology

15.

Genomics and Proteomics

16.

Novel Therapeutics, Targeted Therapies and Gene Therapy

17.

Infectious Diseases, Supportive Care

18

Platelets and Thrombocytopenia

20.

Thrombosis

21.

Quality of Life, Palliative Care and Ethics

   

Author Agreement

By submitting the abstract, the author confirms and agrees to the following:

a.

All authors approve submitting this work for presentation.

b.

The authors have done the work reported in the abstract and take full
responsibility for the contents.

c.

The authors transfer all copyright ownership of the abstract to the EHC2013.

d.

The authors agree to confine their presentation to information in the abstract.

e.

At least one author will be available to present the abstract if selected for the
program.

f.

The author will immediately notify the EHC2013 Scientific Committee if they are
unable to make a presentation or if the presenting author must be changed.

g.

The authors guarantee that clinical studies and any animal tests have proceeded
with the official permission from the proper authorities.

h.

All presenters will be responsible for their own registration fees, hotel and travel
expenses. We regret that we cannot waive registration fees or cover expenses
for any oral or poster presenters.

   

Organised by

Endorsed by

In collaboration with

Supported by

 
 

Latest News

> EHC website exceeds 6,000
...visitors from more than
...30 countries

> Dubai Health Authority
...supportes EHC 2013

> UAE MOH grants 17.5 credit ...hours for EHC 2013 delegates

> EHA grants 14.5 credit hours
...for EHC 2013 delegates

 

Important Dates

20 Feb 13

Final Program available Online

24 Feb 13

Visa applications is closed

27 Feb 13

Online registration
is closed

07 Mar 13

Welcome to
EHC 2013


Back to content | Back to main menu